178 related articles for article (PubMed ID: 35563828)
21. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
Yu J; Schilling L; Eller T; Canalis E
J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
[TBL] [Abstract][Full Text] [Related]
22. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton.
Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T
Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenvironment.
Georgiou KR; Scherer MA; King TJ; Foster BK; Xian CJ
Int J Exp Pathol; 2012 Apr; 93(2):104-14. PubMed ID: 22220905
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.
Fan C; Georgiou KR; King TJ; Xian CJ
J Biomed Biotechnol; 2011; 2011():903097. PubMed ID: 21541196
[TBL] [Abstract][Full Text] [Related]
25. Flavonoid genistein protects bone marrow sinusoidal blood vessels from damage by methotrexate therapy in rats.
Hassanshahi M; Su YW; Khabbazi S; Fan CM; Chen KM; Wang JF; Qian A; Howe PR; Yan DW; Zhou HD; Xian CJ
J Cell Physiol; 2019 Jul; 234(7):11276-11286. PubMed ID: 30565680
[TBL] [Abstract][Full Text] [Related]
26. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss.
Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ
J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats.
Fan C; Georgiou KR; McKinnon RA; Keefe DM; Howe PR; Xian CJ
J Bone Miner Metab; 2016 May; 34(3):277-90. PubMed ID: 26056019
[TBL] [Abstract][Full Text] [Related]
28. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
Canalis E; Sanjay A; Yu J; Zanotti S
Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
[TBL] [Abstract][Full Text] [Related]
29. Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.
Xian CJ; Cool JC; Scherer MA; Macsai CE; Fan C; Covino M; Foster BK
Bone; 2007 Nov; 41(5):842-50. PubMed ID: 17884747
[TBL] [Abstract][Full Text] [Related]
30. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
31. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract][Full Text] [Related]
32. Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats.
Fan CM; Su YW; Howe PR; Xian CJ
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415482
[TBL] [Abstract][Full Text] [Related]
33. Roles of apoptotic chondrocyte-derived CXCL12 in the enhanced chondroclast recruitment following methotrexate and/or dexamethasone treatment.
Su YW; Fan J; Fan CM; Peymanfar Y; Zhang YL; Xian CJ
J Cell Physiol; 2021 Aug; 236(8):5966-5979. PubMed ID: 33438203
[TBL] [Abstract][Full Text] [Related]
34. Panax notoginseng saponins mitigate ovariectomy-induced bone loss and inhibit marrow adiposity in rats.
Fan JZ; Wang Y; Meng Y; Li GW; Chang SX; Nian H; Liang YJ
Menopause; 2015 Dec; 22(12):1343-50. PubMed ID: 26035148
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes.
Sekine C; Koyanagi A; Koyama N; Hozumi K; Chiba S; Yagita H
Arthritis Res Ther; 2012 Mar; 14(2):R45. PubMed ID: 22390640
[TBL] [Abstract][Full Text] [Related]
36. The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis.
Fukushima H; Nakao A; Okamoto F; Shin M; Kajiya H; Sakano S; Bigas A; Jimi E; Okabe K
Mol Cell Biol; 2008 Oct; 28(20):6402-12. PubMed ID: 18710934
[TBL] [Abstract][Full Text] [Related]
37. Physiological notch signaling maintains bone homeostasis via RBPjk and Hey upstream of NFATc1.
Tu X; Chen J; Lim J; Karner CM; Lee SY; Heisig J; Wiese C; Surendran K; Kopan R; Gessler M; Long F
PLoS Genet; 2012; 8(3):e1002577. PubMed ID: 22457635
[TBL] [Abstract][Full Text] [Related]
38. The role of Wnt/β-catenin signaling in enterocyte turnover during methotrexate-induced intestinal mucositis in a rat.
Sukhotnik I; Geyer T; Pollak Y; Mogilner JG; Coran AG; Berkowitz D
PLoS One; 2014; 9(11):e110675. PubMed ID: 25375224
[TBL] [Abstract][Full Text] [Related]
39. Constitutive Activation of β-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice.
Sui X; Deng S; Liu M; Fan L; Wang Y; Xu H; Sun Y; Kishen A; Zhang Q
Cell Physiol Biochem; 2018; 48(5):2091-2102. PubMed ID: 30107384
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-29a mitigates glucocorticoid induction of bone loss and fatty marrow by rescuing Runx2 acetylation.
Ko JY; Chuang PC; Ke HJ; Chen YS; Sun YC; Wang FS
Bone; 2015 Dec; 81():80-88. PubMed ID: 26141838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
